CVNA (NYSE: CVNA) holder plans sale of 40,000 common shares via Form 144

Rhea-AI Filing Summary

An existing holder of CVNA common stock has filed a notice of proposed sale of 40,000 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $15,990,800.00 and 141,423,193 shares of common stock outstanding. The shares to be sold were acquired on 12/08/2025 via an exercise of stock options paid in cash on the same date.

Over the past three months, a 10b5-1 sales plan for BHJC Trust reported additional sales of CVNA common stock: 10,000 shares on each of 10/01/2025, 11/03/2025, and 12/01/2025, with gross proceeds of $3,892,725.00, $3,245,730.00, and $3,771,101.00, respectively.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40000	15990800.00	141423193	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/08/2025	Exercise of Stock Options	Issuer			40000	12/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway Tempe AZ 85281	COMMON	12/01/2025	10000	3771101.00
10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway Tempe AZ 85281	COMMON	11/03/2025	10000	3245730.00
10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway Tempe AZ 85281	COMMON	10/01/2025	10000	3892725.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing indicate for CVNA stock?

The filing shows that a holder of CVNA common stock has notified regulators of a planned sale of 40,000 shares on the NYSE, with an aggregate market value of $15,990,800.00 based on the figures disclosed.

How many CVNA shares are proposed to be sold under this notice?

The notice covers a proposed sale of 40,000 shares of CVNA common stock, to be executed through Morgan Stanley Smith Barney LLC.

How were the 40,000 CVNA shares being sold acquired?

The 40,000 CVNA common shares were acquired on 12/08/2025 through an exercise of stock options, with the purchase price paid in cash on that date.

What prior CVNA stock sales are disclosed for the past three months?

A 10b5-1 sales plan for BHJC Trust sold 10,000 CVNA common shares on each of 10/01/2025, 11/03/2025, and 12/01/2025, for gross proceeds of $3,892,725.00, $3,245,730.00, and $3,771,101.00, respectively.

How many CVNA shares are outstanding according to this filing?

The filing states that there are 141,423,193 shares of CVNA common stock outstanding, providing context for the size of the proposed 40,000-share sale.

Which broker is handling the planned CVNA share sale and on what exchange?

The proposed sale of 40,000 CVNA common shares is listed with Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are to be sold on the NYSE.